Mariagrazia Pizza | |
---|---|
Born | |
Alma mater | University of Naples Federico II |
Awards | EMBO Member (2000) [1] |
Scientific career | |
Fields | Vaccines Pathogenesis [2] |
Institutions |
Mariagrazia Pizza MAE is an Italian vaccine researcher who is a professor at Imperial College London. [2] [4] She worked as Senior Scientific Director for Bacterial Vaccines at GSK plc. [5] [6] She was involved with the development of the first pertussis vaccine. In 2023, she was awarded the IVI-SK bioscience Park MahnHoon Award. [7]
Pizza was born in Eboli, Italy and lived there until 1980. [8] She studied chemistry and pharmaceutical science at the University of Naples Federico II. [9] Her dissertation used nuclear magnetic resonance to explore the structure of opioid peptides. [9] When a family member became ill, she decided to learn more about pharmaceutical design. She moved to the European Molecular Biology Laboratory in Heidelberg, where she learnt molecular biology and engineering. [9]
Pizza has focused on the design and development of new vaccines. In 1986, she joined Sclavo, a vaccine research centre in Siena. She spent six years there, contributing to the development of the first pertussis vaccine, [9] which was able to protect infants, and was safer and more immuno-active than other pertussis vaccines on the market. [9] Sclavo was sold to Chiron, which was eventually acquired by Novartis. Motivated by their success and advances in whole genome sequencing, Pizza started working on a Meningococcal vaccine. [9] [10] She joined GSK plc in 2016. [8]
In 2023, Pizza joined the faculty at Imperial College London [ citation needed ]. She is an Honorary Visiting Professor at the University of Leicester. [3]
Pizza has two children. [9]